Myeloma

Oncology·MeSH: Neoplasms, Plasma Cell

Prevalence

17.0 / 100K

Incidence

7.0 / 100K/yr

298 drugs in development·78 companies·9 clinical trials

Drug Pipeline by Phase

Approved(13)

Drug	Company
abecma	2seventy bio, Inc. (TSVT)
bortezomib	Aptinyx Inc. (APTX)
bortezomib	MAIA Biotechnology, Inc. (MAIA)
bortezomib	Mersana Therapeutics, Inc. (MRSN)
bortezomib	DR REDDYS LABORATORIES LTD (RDY)
bortezomib	Teva Pharmaceutical Industries Limited (TEVA)
carmustine	Amneal Pharmaceuticals, Inc. (AMRX)
clonoSEQ	Adaptive Biotechnologies Corp (ADPT)
cyclophosphamide	NEXUS BIOPHARMA INC (NEXS)
evomela	CASI Pharmaceuticals, Inc (DE) (CASI)
lenalidomide	Mylan II B.V. (MYL)
thalomid	CELGENE CORP /DE/ (CELG)
zoledronic acid	Amneal Pharmaceuticals, Inc. (AMRX)

Phase 3(77)

Drug	Company
anitocabtagene autoleucel	GILEAD SCIENCES, INC. (GILD)
Anitocabtagene Autoleucel	FATE THERAPEUTICS INC (FATE)
arlocabtagene autoleucel	Juno Therapeutics, Inc. (JUNO)
Arlocabtagene Autoleucel	BRISTOL MYERS SQUIBB CO (BMY)
AZD0120	ASTRAZENECA PLC (AZN)
azd0305	ASTRAZENECA PLC (AZN)
bb2121	CELGENE CORP /DE/ (CELG)
belumosudil	Sanofi (SNY)
Bendamustine Hydrochloride	Filana Therapeutics Inc. (FLNA)
bl-8040 1.25 mg/kg + g-csf	BioLineRx Ltd. (BLRX)
bl-m24d1	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
bl-m24d1	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
bortezomib	AbbVie Inc. (ABBV)
Bortezomib	Sanofi (SNY)
carfilzomib	Sanofi (SNY)
Carfilzomib	BRISTOL MYERS SQUIBB CO (BMY)
Carfilzomib	AbbVie Inc. (ABBV)
copal digital sphygmomamometer ua-550	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital sphygmomanometer ua-510	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital sphygmomanometer ua-535	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital sphygmomanometer ua-540	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital sphygmomanometer ua-560	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital thermometer uf-10	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital thermometer uf-12	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal digital thermometer uf-22b	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
copal ua-512 digital blood pressure monitor	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
daratumumab	REGENERON PHARMACEUTICALS, INC. (REGN)
daratumumab	Juno Therapeutics, Inc. (JUNO)
daratumumab	ASTRAZENECA PLC (AZN)
daratumumab	GH Research PLC (GHRS)
Daratumumab	BRISTOL MYERS SQUIBB CO (BMY)
Daratumumab	Filana Therapeutics Inc. (FLNA)
daratumumab sc	GH Research PLC (GHRS)
descartes-11	Cartesian Therapeutics, Inc. (RNAC)
descartes-15	Cartesian Therapeutics, Inc. (RNAC)
digital sphygmomanometer model 7620	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
diphenhydramine or equivalent	Sanofi (SNY)
elotuzumab	REGENERON PHARMACEUTICALS, INC. (REGN)
elotuzumab	GH Research PLC (GHRS)
elotuzumab	AbbVie Inc. (ABBV)
Elotuzumab	Merus N.V. (MRUS)
fludarabine	CELGENE CORP /DE/ (CELG)
Fosaprepitant	Merus N.V. (MRUS)
gamunex-c	Grifols S.A. (GRFS)
Iberdomide	BRISTOL MYERS SQUIBB CO (BMY)
idecabtagene vicleucel	CELGENE CORP /DE/ (CELG)
igi	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
igi	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
IGI, 10%	Merus N.V. (MRUS)
induction therapy	GH Research PLC (GHRS)
Isatuximab	Sanofi (SNY)
isatuximab iv	Sanofi (SNY)
isatuximab sc	Sanofi (SNY)
Manufactured Anti-BCMA CAR-T cells	Filana Therapeutics Inc. (FLNA)
Melphalan	ENANTA PHARMACEUTICALS INC (ENTA)
Mezigdomide	BRISTOL MYERS SQUIBB CO (BMY)
montelukast	Sanofi (SNY)
Montelukast	Sanofi (SNY)
montelukast or equivalent	Sanofi (SNY)
Pomalidomide	BRISTOL MYERS SQUIBB CO (BMY)
Pomalidomide	AbbVie Inc. (ABBV)
Pomalidomide	BeOne Medicines Ltd. (ONC)
Pomalidomide	Merus N.V. (MRUS)
regn5459	REGENERON PHARMACEUTICALS, INC. (REGN)
Selinexor	AbbVie Inc. (ABBV)
sonrotoclax	BeOne Medicines Ltd. (ONC)
tak-079	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-079	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
takeda medical digital sphygmomanometer	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
talquetamab	GH Research PLC (GHRS)
Talquetamab	Merus N.V. (MRUS)
teclistamab	GH Research PLC (GHRS)
Teclistamab	Merus N.V. (MRUS)
teclistamab monotherapy	GH Research PLC (GHRS)
Tocilizumab	ENANTA PHARMACEUTICALS INC (ENTA)
Tropisetron	Merus N.V. (MRUS)
Venetoclax	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 2(61)

Drug	Company
allo-715	Allogene Therapeutics, Inc. (ALLO)
Bendamustine	FATE THERAPEUTICS INC (FATE)
Bortezomib	Coeptis Therapeutics Holdings Inc. (COEP)
Bortezomib	FATE THERAPEUTICS INC (FATE)
Busulfan	ENANTA PHARMACEUTICALS INC (ENTA)
Carfilzomib	Crinetics Pharmaceuticals, Inc. (CRNX)
Carfilzomib	FATE THERAPEUTICS INC (FATE)
CC-95266	Filana Therapeutics Inc. (FLNA)
cemsidomide	C4 Therapeutics, Inc. (CCCC)
Cilta-cel	Filana Therapeutics Inc. (FLNA)
Daratumumab	Coeptis Therapeutics Holdings Inc. (COEP)
Daratumumab	FATE THERAPEUTICS INC (FATE)
Daratumumab and Recombinant Human Hyaluronidase	Crinetics Pharmaceuticals, Inc. (CRNX)
Daratumumab and Recombinant Human Hyaluronidase	FATE THERAPEUTICS INC (FATE)
Daratumumab SC	FATE THERAPEUTICS INC (FATE)
diphenhydramine	Sanofi (SNYNF)
elotuzumab	BRISTOL MYERS SQUIBB CO (BMY)
Elranatamab	Crinetics Pharmaceuticals, Inc. (CRNX)
Elranatamab	ENANTA PHARMACEUTICALS INC (ENTA)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
Fludarabine	FATE THERAPEUTICS INC (FATE)
G-CSF	PTC THERAPEUTICS, INC. (PTCT)
G-CSF	Structure Therapeutics Inc. (GPCR)
G-CSF	ENANTA PHARMACEUTICALS INC (ENTA)
gpc-100	EXICURE, INC. (XCUR)
GPC-100	Structure Therapeutics Inc. (GPCR)
GPC-100	PTC THERAPEUTICS, INC. (PTCT)
iberdomide	CELGENE CORP /DE/ (CELG)
Ide-cel	Merus N.V. (MRUS)
imetelstat	GERON CORP (GERN)
incb001158	Incyte Corp. (INCY)
iph2101	Innate Pharma SA (IPHYF)
iph2101	Innate Pharma S.A. (IPHA)
isatuximab	Sanofi (SNY)
isatuximab sc-obds	Sanofi (SNY)
isatuximab sc-obds	Sanofi (SNY)
LCAR-B38M CAR-T Cell	Legend Biotech Corp (LEGN)
nexi-002	NexImmune, Inc. (NEXI)
Part 1	FATE THERAPEUTICS INC (FATE)
Part 2	FATE THERAPEUTICS INC (FATE)
Plerixafor	ENANTA PHARMACEUTICALS INC (ENTA)
Pomalidomide	Coeptis Therapeutics Holdings Inc. (COEP)
Pomalidomide	Crinetics Pharmaceuticals, Inc. (CRNX)
Pomalidomide	FATE THERAPEUTICS INC (FATE)
prophylaxis a	GH Research PLC (GHRS)
prophylaxis b	GH Research PLC (GHRS)
prophylaxis c	GH Research PLC (GHRS)
prophylaxis d	GH Research PLC (GHRS)
Propranolol	Structure Therapeutics Inc. (GPCR)
Propranolol	PTC THERAPEUTICS, INC. (PTCT)
Propranolol Hydrochloride	Structure Therapeutics Inc. (GPCR)
ramantamig	GH Research PLC (GHRS)
sar446523	Sanofi (SNYNF)
Selinexor	FATE THERAPEUTICS INC (FATE)
Selinexor	Coeptis Therapeutics Holdings Inc. (COEP)
Talquetamab	Filana Therapeutics Inc. (FLNA)
Talquetamab	FATE THERAPEUTICS INC (FATE)
Teclistamab	Coeptis Therapeutics Holdings Inc. (COEP)
Teclistamab	Crinetics Pharmaceuticals, Inc. (CRNX)
Teclistamab	Filana Therapeutics Inc. (FLNA)
Teclistamab	FATE THERAPEUTICS INC (FATE)

Phase 1(69)

Drug	Company
ABBV-438	AbbVie Inc. (ABBV)
ABT-199	AbbVie Inc. (ABBV)
ACLX-001	Arcellx, Inc. (ACLX)
Alnuctamab	BRISTOL MYERS SQUIBB CO (BMY)
anti-bcma car-t	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
Autologous BCMA-targeting CAR T cells	Filana Therapeutics Inc. (FLNA)
Bendamustine	Filana Therapeutics Inc. (FLNA)
bl-m24d1	NYMOX PHARMACEUTICAL CORP (NYMXF)
BMS-986453	Filana Therapeutics Inc. (FLNA)
Carfilzomib	Filana Therapeutics Inc. (FLNA)
Carfilzomib	Coeptis Therapeutics Holdings Inc. (COEP)
Carfilzomib	Merus N.V. (MRUS)
Carfilzomib	Structure Therapeutics Inc. (GPCR)
CB-011	Caribou Biosciences, Inc. (CRBU)
cb-5339	CASI Pharmaceuticals, Inc (DE) (CASI)
cid-103	CASI Pharmaceuticals, Inc (DE) (CASI)
CLN-619	Cullinan Therapeutics, Inc. (CGEM)
daratumumab	Teva Pharmaceutical Industries Limited (TEVA)
Daratumumab and Recombinant Human Hyaluronidase	Coeptis Therapeutics Holdings Inc. (COEP)
diphenhydramine	Sanofi (SNY)
Efbalropendekin alfa (XmAb306 / RG6323)	Xencor Inc (XNCR)
elranatamab	C4 Therapeutics, Inc. (CCCC)
elranatamab	PFIZER INC (PFE)
Elranatamab	BRISTOL MYERS SQUIBB CO (BMY)
Etentamig	AbbVie Inc. (ABBV)
ezm0414	Epizyme, Inc. (EPZM)
fcarh143	Juno Therapeutics, Inc. (JUNO)
fludarabine	Cartesian Therapeutics, Inc. (RNAC)
FT576	FATE THERAPEUTICS INC (FATE)
Granulocyte Colony-Stimulating Factor	Merus N.V. (MRUS)
hdp-101	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
hdp-101	NYMOX PHARMACEUTICAL CORP (NYMXF)
hpn217	Harpoon Therapeutics, Inc. (HARP)
iberdomide	PFIZER INC (PFE)
iberdomide	AbbVie Inc. (ABBV)
intravenous etentamig	AbbVie Inc. (ABBV)
isatuximab sar650984 iv	Sanofi (SNY)
isatuximab sar650984 sc	Sanofi (SNY)
jcarh125	Juno Therapeutics, Inc. (JUNO)
jnj-79635322	GH Research PLC (GHRS)
jnj-87562761	GH Research PLC (GHRS)
mcarh171	Juno Therapeutics, Inc. (JUNO)
mk-4002	Merck & Co., Inc. (MRK)
modakafusp alfa	Teva Pharmaceutical Industries Limited (TEVA)
nirogacestat	Allogene Therapeutics, Inc. (ALLO)
nxc-201	Immix Biopharma, Inc. (IMMX)
p-bcma-allo1	Poseida Therapeutics, Inc. (PSTX)
p-bcma-allo1 car-t cells	Poseida Therapeutics, Inc. (PSTX)
p-bcmacd19-allo1	Poseida Therapeutics, Inc. (PSTX)
phe885	Novartis AG (NVS)
phe885	NOVARTIS AG (NVSEF)
rimiducid	Poseida Therapeutics, Inc. (PSTX)
rimiducid may be administered as indicated	Poseida Therapeutics, Inc. (PSTX)
sar439459	Sanofi (SNY)
sar442085	Sanofi (SNY)
sar445514	Sanofi (SNY)
sar445514	Sanofi (SNYNF)
sar446523	Sanofi (SNY)
Selvigaltin	FATE THERAPEUTICS INC (FATE)
Selvigaltin	Coeptis Therapeutics Holdings Inc. (COEP)
shr-9539	Eiger BioPharmaceuticals, Inc. (EIGR)
sti-1492	Sorrento Therapeutics, Inc. (SRNE)
subcutaneous etentamig	AbbVie Inc. (ABBV)
TAK-079	Merus N.V. (MRUS)
tak-573	Teva Pharmaceutical Industries Limited (TEVA)
TNB-383B	AbbVie Inc. (ABBV)
Tocilizumab	ADMA BIOLOGICS, INC. (ADMA)
tti-622	Trillium Therapeutics Inc. (TRIL)
Venetoclax	ADMA BIOLOGICS, INC. (ADMA)

Preclinical(7)

Drug	Company
al102	OLD AYALA, INC (AYLA)
cd38-diagnostic	COEPTIS THERAPEUTICS INC. (NDYN)
CD38-Diagnostic	Coeptis Therapeutics Holdings Inc. (COEP)
cd38-gear-nk	COEPTIS THERAPEUTICS INC. (NDYN)
CD38-GEAR-NK	Coeptis Therapeutics Holdings Inc. (COEP)
kb-9558	Kronos Bio, Inc. (KRON)
sc255	Sana Biotechnology, Inc. (SANA)

Unknown(4)

Drug	Company
HLX14	Organon & Co. (OGN)
immunomodulatory agent	GH Research PLC (GHRS)
LCAR- F33S cells intravenous infusion	Legend Biotech Corp (LEGN)
proteasome inhibitor	GH Research PLC (GHRS)

Phase 1/Phase 2(30)

Drug	Company
ABBV-453	AbbVie Inc. (ABBV)
AUTO8	Autolus Therapeutics plc (AUTL)
belantamab mafodotin	Sanofi (SNY)
belantamab mafodotin	Sanofi (SNYNF)
belantamab mafodotin	Karyopharm Therapeutics Inc. (KPTI)
Carfilzomib	BeOne Medicines Ltd. (ONC)
cemiplimab	Sanofi (SNY)
Cemiplimab	Sanofi (SNY)
daratumumab	BeOne Medicines Ltd. (ONC)
daratumumab	Genmab A/S (GMAB)
daratumumab	GENMAB A/S (GNMSF)
daratumumab	Karyopharm Therapeutics Inc. (KPTI)
Daratumumab	BeOne Medicines Ltd. (ONC)
daratumumab sc	Incyte Corp. (INCY)
elotuzumab	Karyopharm Therapeutics Inc. (KPTI)
elranatamab	ASTRAZENECA PLC (AZN)
evorpacept	Sanofi (SNY)
evorpacept	Sanofi (SNYNF)
gen3014	GENMAB A/S (GNMSF)
gen3014	Genmab A/S (GMAB)
isatuximab sar650984	Sanofi (SNY)
isatuximab SAR650984	Sanofi (SNY)
ixazomib	Karyopharm Therapeutics Inc. (KPTI)
linvoseltamab	REGENERON PHARMACEUTICALS, INC. (REGN)
mezigdomide	Karyopharm Therapeutics Inc. (KPTI)
pegenzileukin	Sanofi (SNYNF)
pegenzileukin	Sanofi (SNY)
regn17372+linvoseltamab	REGENERON PHARMACEUTICALS, INC. (REGN)
regn7945+linvoseltamab	REGENERON PHARMACEUTICALS, INC. (REGN)
sar439459	Sanofi (SNYNF)

Phase 2/Phase 3(2)

Drug	Company
Daratumumab	AbbVie Inc. (ABBV)
fludarabine	GH Research PLC (GHRS)

Phase 4(35)

Drug	Company
Acetaminophen	Structure Therapeutics Inc. (GPCR)
Acetaminophen	Filana Therapeutics Inc. (FLNA)
Belumosudil	Sanofi (SNY)
Belumosudil mesylate	Sanofi (SNY)
BMS-986393	BRISTOL MYERS SQUIBB CO (BMY)
cilta-cel	GH Research PLC (GHRS)
Famotidine	PROTHENA CORP PUBLIC LTD CO (PRTA)
Famotidine	Cidara Therapeutics, Inc. (CDTX)
Famotidine	Structure Therapeutics Inc. (GPCR)
Famotidine	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Famotidine	Filana Therapeutics Inc. (FLNA)
ixazomib	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
ixazomib	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Loratadine	Filana Therapeutics Inc. (FLNA)
Loratadine	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Loratadine	Structure Therapeutics Inc. (GPCR)
Loratadine	Cidara Therapeutics, Inc. (CDTX)
Montelukast	PROTHENA CORP PUBLIC LTD CO (PRTA)
Montelukast	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Montelukast	Cidara Therapeutics, Inc. (CDTX)
Montelukast	Filana Therapeutics Inc. (FLNA)
Motixafortide	Structure Therapeutics Inc. (GPCR)
Motixafortide	Cidara Therapeutics, Inc. (CDTX)
Motixafortide	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Motixafortide	Filana Therapeutics Inc. (FLNA)
Motixafortide	PROTHENA CORP PUBLIC LTD CO (PRTA)
mRNA-2808	Moderna, Inc. (MRNA)
ogsiveo	SpringWorks Therapeutics, Inc. (SWTX)
Olanzapine	Merus N.V. (MRUS)
Recombinant Granulocyte Colony-Stimulating Factor	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Recombinant Granulocyte Colony-Stimulating Factor	Filana Therapeutics Inc. (FLNA)
Recombinant Granulocyte Colony-Stimulating Factor	PROTHENA CORP PUBLIC LTD CO (PRTA)
Siltuximab	ENANTA PHARMACEUTICALS INC (ENTA)
teclistamab	JOHNSON & JOHNSON (JNJ)
tocilizumab	REGENERON PHARMACEUTICALS, INC. (REGN)

Compare drugs

abecma vs bortezomib abecma vs carmustine abecma vs clonoSEQ

Frequently asked questions

How many drugs are in development for Myeloma?

BioSniper tracks 298 drugs in development for Myeloma across 78 companies.

How many clinical trials target Myeloma?

There are 9 clinical trials targeting Myeloma tracked by BioSniper.

What is the prevalence of Myeloma?

The estimated prevalence of Myeloma is approximately 17.0 per 100,000 population.

Deep-dive into Myeloma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis